() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Search for: "ICC international Cannabis"

Wayland Addresses Transaction with ICC International Cannabis Corp.

May 02, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially affect the Company’s sale of a 49.9% interest in its international asset and license portfolio to ICC International Cannabis Corp (the “Transaction”).
Read more

ICC International Cannabis Announces Effective Date for Name Change

Sept. 19, 2018 (GLOBE NEWSWIRE) -- ICC International Cannabis Corp. (formerly Kaneh Bosm BioTechnology Inc.) (CSE: KBB)(FWB: 8K51)(OTC: KNHBF)( the “Company”) is pleased to announce that further to its news release dated September 17, 2018, the Company has changed its name from “Kaneh Bosm BioTechnology Inc.” to “ICC International Cannabis Corp.”.  The Company’s common shares will begin trading under the new name on September 20, 2018.  There will be no change to the symbol and the Company’s common shares will continue to trade under the ticker “KBB”.  The CUSIP number assigned to the Company’s common shares following the name change is 451079107 (ISIN: CA45107911078). No action is required to be taken by shareholders with respect to the name change. Outstanding share certificates are not affected by the name change and do not need to be exchanged.
Read more

Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.

Sept. 17, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE: KBB)(FWB: 8K51)(OTC: KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. The Transaction provides Auxly access to a significant and established portfolio of international cannabis licences, assets and distribution networks. As a result of the Transaction, Auxly believes that it has substantially accelerated its entry into numerous international cannabis markets and partnered with an ambitious team focused on future growth. 
Read more
Get $50 in free trades.